Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03924752 · ClinicalTrials.gov registry record · NA
Powered Hip Exoskeleton Assistance Study
A NA study of Lower Limb Injury, sponsored by Georgia Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03924752: Completed NA study of Lower Limb Injury, sponsored by Georgia Institute of Technology.
NCT03924752 is a NA study of Lower Limb Injury that has completed, run by Georgia Institute of Technology. The registered enrollment target is 10 participants, below the 52-participant average among 3 other Lower Limb Injury trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03924752, a NA study of Lower Limb Injury, has completed, sponsored by Georgia Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The increased metabolic and biomechanical demands of ambulation limit community mobility in persons with lower limb disability due to neurological damage. There is a critical need for improving the locomotion capabilities of individuals who have walking impairments due to disease to increase their community mobility, independence, and health. Robotic exoskeletons have the potential to assist these individuals by increasing community mobility to improve quality of life. While these devices have incredible potential, current technology does not support dynamic movements common with locomotion such as transitioning between different gaits and supporting a wide variety of walking speeds. One significant challenge in achieving community ambulation with exoskeletons is providing an adaptive control system to accomplish a wide variety of locomotor tasks. Many exoskeletons today are developed without a detailed understanding of the effect of the device on the human musculoskeletal system. This research is interested in studying the question of how the control system affects human biomechanics including kinematic, kinetics and muscle activation patterns. By optimizing exoskeleton controllers based on human biomechanics and adapting control based on task, the biggest benefit to patient populations will be achieved to help advance the state-of-the-art with assistive hip exoskeletons.
Primary Outcome
Measure Description: The subject's preferred overground walking speed while wearing a powered hip exoskeleton was recorded. During walking, the exoskeleton provided hip assistance. There was a total of five walking conditions that were evaluated: 1) level-ground, 2) ramp ascent, 3) ramp descent, 4) stair ascent and 5) stair descent. The ramp incline was set to 9.2 degrees and the stair height was set to 15.24 cm. The user's preferred walking speed was calculated by looking at the distance travel
Conditions Studied
Interventions
- DEVICE Powered hip exoskeleton
Study Locations (1)
Georgia
- Exoskeleton and Prosthetic Intelligent Controls Lab - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-02-13 |
| Est. Completion | 2021-03-15 |
| Phase | NA |
What the finished NCT03924752 record still lists
NCT03924752 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 52-participant average among 3 other Lower Limb Injury trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Lower Limb Injury appearing as the primary indexed condition, and to 1 intervention - of which Powered hip exoskeleton is the first listed.
NCT03924752 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT03924752 about?
NCT03924752 is a clinical study titled "Powered Hip Exoskeleton Assistance Study". The increased metabolic and biomechanical demands of ambulation limit community mobility in persons with lower limb disability due to neurological damage. There is a critical need for improving the locomotion capabilities of individuals who have walking impairments due to disease to increase their c...
What is the current status of trial NCT03924752?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-02-13. Estimated completion is 2021-03-15.
What conditions does trial NCT03924752 study?
This clinical trial studies the following conditions: Lower Limb Injury.
What interventions are being tested in trial NCT03924752?
The interventions under investigation include: Powered hip exoskeleton (DEVICE).
Who is sponsoring clinical trial NCT03924752?
This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03924752 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lower Limb Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI